{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:39:23Z","timestamp":1792528763506,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03465-6","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:45:37Z","timestamp":1792467937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging Role of the Tumor Microenvironment in the Development of Metastasis, Drug Resistance, and Molecular Targeted Strategies A Commentary"],"prefix":"10.1007","volume":"43","author":[{"given":"Rashid","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajaz Ahmad","family":"Waza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufiyan","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"issue":"11","key":"3465_CR1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","volume":"21","author":"JS Brown","year":"2023","unstructured":"Brown JS, Amend SR, Austin RH, Gatenby RA, Hammarlund EU, Pienta KJ. Updating the Definition of Cancer. Mol Cancer Res. 2023;21(11):1142\u20137.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3465_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","volume":"10","author":"M Tufail","year":"2025","unstructured":"Tufail M, Jiang CH, Li N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Signal Transduct Target Ther. 2025;10(1):227.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3465_CR3","doi-asserted-by":"publisher","first-page":"24230","DOI":"10.1038\/s41598-024-75265-9","volume":"14","author":"E Heninger","year":"2024","unstructured":"Heninger E, Breneman MT, Recchia EE, Kerr SC, Dogru RE, Sharifi MN, et al. Dynamic reciprocal interactions between activated T cells and tumor associated macrophages drive macrophage reprogramming and proinflammatory T cell migration within prostate tumor models. Sci Rep. 2024;14(1):24230.","journal-title":"Sci Rep"},{"key":"3465_CR4","doi-asserted-by":"crossref","unstructured":"Glabman RA, Choyke PL, Sato N. Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy. Cancers (Basel). 2022;14(16). 3906. DOI: 10.3390\/cancers14163906.","DOI":"10.3390\/cancers14163906"},{"issue":"1","key":"3465_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41420-025-02566-x","volume":"11","author":"H Masuda","year":"2025","unstructured":"Masuda H. Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review. Cell Death Discov. 2025;11(1):341.","journal-title":"Cell Death Discov"},{"issue":"2","key":"3465_CR6","doi-asserted-by":"publisher","first-page":"021502","DOI":"10.1063\/5.0195244","volume":"8","author":"S Benmelech","year":"2024","unstructured":"Benmelech S, Le T, McKay M, Nam J, Subramaniam K, Tellez D, et al. Biophysical and biochemical aspects of immune cell-tumor microenvironment interactions. APL Bioeng. 2024;8(2):021502.","journal-title":"APL Bioeng"},{"key":"3465_CR7","doi-asserted-by":"publisher","first-page":"864739","DOI":"10.3389\/fimmu.2022.864739","volume":"13","author":"JY Mun","year":"2022","unstructured":"Mun JY, Leem SH, Lee JH, Kim HS. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment. Front Immunol. 2022;13:864739.","journal-title":"Front Immunol"},{"key":"3465_CR8","doi-asserted-by":"publisher","unstructured":"Lopez-Gil JC, Martin-Hijano L, Hermann PC, Sainz B. Jr. The CXCL12 Crossroads in Cancer Stem Cells and Their Niche. Cancers (Basel). 2021;13(3):469. https:\/\/doi.org\/10.3390\/cancers13030469","DOI":"10.3390\/cancers13030469"},{"issue":"1","key":"3465_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-025-02282-1","volume":"24","author":"A Semeradtova","year":"2025","unstructured":"Semeradtova A, Liegertova M, Herma R, Capkova M, Brignole C, Del Zotto G. Extracellular vesicles in cancer s communication: messages we can read and how to answer. Mol Cancer. 2025;24(1):86.","journal-title":"Mol Cancer"},{"key":"3465_CR10","doi-asserted-by":"publisher","unstructured":"Dalton CJ, Lemmon CA, Fibronectin. Molecular Structure, Fibrillar Structure, and Mechanochemical Signaling. Cells. 2021;10(9):2443. https:\/\/doi.org\/10.3390\/cells10092443","DOI":"10.3390\/cells10092443"},{"issue":"1","key":"3465_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","volume":"10","author":"Y Li","year":"2025","unstructured":"Li Y, Liu F, Cai Q, Deng L, Ouyang Q, Zhang XH, et al. Invasion and metastasis in cancer: molecular insights and therapeutic targets. Signal Transduct Target Ther. 2025;10(1):57.","journal-title":"Signal Transduct Target Ther"},{"key":"3465_CR12","doi-asserted-by":"publisher","first-page":"828875","DOI":"10.3389\/fimmu.2022.828875","volume":"13","author":"R Abou Khouzam","year":"2022","unstructured":"Abou Khouzam R, Zaarour RF, Brodaczewska K, Azakir B, Venkatesh GH, Thiery J, et al. The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? Front Immunol. 2022;13:828875.","journal-title":"Front Immunol"},{"issue":"1","key":"3465_CR13","doi-asserted-by":"publisher","first-page":"e32533","DOI":"10.1097\/MD.0000000000032533","volume":"102","author":"L Hu","year":"2023","unstructured":"Hu L, Hu J, Huang Y, Zheng S, Yin J, Li X, et al. Hypoxia-mediated activation of hypoxia-inducible factor-1alpha in head and neck squamous cell carcinoma: A review. Med (Baltim). 2023;102(1):e32533.","journal-title":"Med (Baltim)"},{"issue":"4","key":"3465_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","volume":"31","author":"HP Zhang","year":"2024","unstructured":"Zhang HP, Jiang RY, Zhu JY, Sun KN, Huang Y, Zhou HH, et al. PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer. Breast Cancer. 2024;31(4):539\u201351.","journal-title":"Breast Cancer"},{"key":"3465_CR15","doi-asserted-by":"publisher","first-page":"5803639","DOI":"10.1155\/2020\/5803639","volume":"2020","author":"K Xiao","year":"2020","unstructured":"Xiao K, Liu C, Tu Z, Xu Q, Chen S, Zhang Y, et al. Activation of the NF-kappaB and MAPK Signaling Pathways Contributes to the Inflammatory Responses, but Not Cell Injury, in IPEC-1 Cells Challenged with Hydrogen Peroxide. Oxid Med Cell Longev. 2020;2020:5803639.","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"3465_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12032-025-02945-5","volume":"42","author":"R Mir","year":"2025","unstructured":"Mir R, Javid J, Ullah MF, Alrdahe S, Altedlawi IA, Mustafa SK, et al. Metabolic reprogramming and functional crosstalk within the tumor microenvironment (TME) and A Multi-omics anticancer approach. Med Oncol. 2025;42(9):373.","journal-title":"Med Oncol"},{"issue":"7","key":"3465_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/2211-5463.13415","volume":"12","author":"MK Ichikawa","year":"2022","unstructured":"Ichikawa MK, Endo K, Itoh Y, Osada AH, Kimura Y, Ueki K, et al. Ets family proteins regulate the EMT transcription factors Snail and ZEB in cancer cells. FEBS Open Bio. 2022;12(7):1353\u201364.","journal-title":"FEBS Open Bio"},{"key":"3465_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2023.10.001","volume":"97","author":"M Saitoh","year":"2023","unstructured":"Saitoh M. Transcriptional regulation of EMT transcription factors in cancer. Semin Cancer Biol. 2023;97:21\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"3465_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","volume":"77","author":"R Lugano","year":"2020","unstructured":"Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77(9):1745\u201370.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3465_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, Wang Y, Mu J, Zeng Q, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6(1):218.","journal-title":"Signal Transduct Target Ther"},{"key":"3465_CR21","doi-asserted-by":"publisher","first-page":"115425","DOI":"10.1016\/j.biopha.2023.115425","volume":"166","author":"Z Zhao","year":"2023","unstructured":"Zhao Z, Li T, Sun L, Yuan Y, Zhu Y. Potential mechanisms of cancer-associated fibroblasts in therapeutic resistance. Biomed Pharmacother. 2023;166:115425.","journal-title":"Biomed Pharmacother"},{"key":"3465_CR22","doi-asserted-by":"publisher","unstructured":"Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int J Mol Sci. 2021;23(1).:146. https:\/\/doi.org\/10.3390\/ijms23010146","DOI":"10.3390\/ijms23010146"},{"key":"3465_CR23","doi-asserted-by":"publisher","unstructured":"Lira GA, de Azevedo FM, Lins IGDS, Marques IL, Lira GA, Eich C, et al. High M2-TAM Infiltration and STAT3\/NF-\u03baB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer. Cancers (Basel). 2024;16(14):2496. https:\/\/doi.org\/10.3390\/cancers16142496","DOI":"10.3390\/cancers16142496"},{"issue":"6","key":"3465_CR24","first-page":"100870","volume":"18","author":"M Deng","year":"2023","unstructured":"Deng M, Wu S, Huang P, Liu Y, Li C, Zheng J. Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence. Asian J Pharm Sci. 2023;18(6):100870.","journal-title":"Asian J Pharm Sci"},{"issue":"7578","key":"3465_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329\u201335.","journal-title":"Nature"},{"issue":"6","key":"3465_CR26","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/cas.70056","volume":"116","author":"M Yuan","year":"2025","unstructured":"Yuan M, Zheng X, Zheng S, Li H, Zhang X, Chen Y, et al. Exosomal PKM2: A Noninvasive Diagnostic Marker Linking Macrophage Metabolic Reprogramming to Gastric Cancer Pathogenesis. Cancer Sci. 2025;116(6):1537\u201349.","journal-title":"Cancer Sci"},{"issue":"6","key":"3465_CR27","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado H, Ale\u010dkovi\u0107 M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883\u201391. https:\/\/doi.org\/10.1038\/nm.2753.","journal-title":"Nat Med"},{"key":"3465_CR28","doi-asserted-by":"publisher","unstructured":"Chai X, Tao Q, Li L. Spatiotemporal Heterogeneity of Tumor Glucose Metabolism Reprogramming: From Single-Cell Mechanisms to Precision Interventions. Int J Mol Sci. 2025;26(14).6901. https:\/\/doi.org\/10.3390\/ijms26146901","DOI":"10.3390\/ijms26146901"},{"key":"3465_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jare.2024.05.031","volume":"71","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang X, Gu W, Su H, Wang X, Wang X, et al. Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects. J Adv Res. 2025;71:399\u2013413.","journal-title":"J Adv Res"},{"key":"3465_CR30","doi-asserted-by":"publisher","unstructured":"Trejo-Solis C, Silva-Adaya D, Serrano-Garcia N, Magana-Maldonado R, Jimenez-Farfan D, Ferreira-Guerrero E et al. Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma. Int J Mol Sci. 2023;24(24):17633. https:\/\/doi.org\/10.3390\/ijms242417633","DOI":"10.3390\/ijms242417633"},{"key":"3465_CR31","doi-asserted-by":"publisher","unstructured":"Perez-Tomas R, Perez-Guillen I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel). 2020;12(11).3244. https:\/\/doi.org\/10.3390\/cancers12113244","DOI":"10.3390\/cancers12113244"},{"key":"3465_CR32","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1002\/mog2.70068","volume":"5","author":"P Tang","year":"2026","unstructured":"Tang P, et al. Oxidative stress in the tumor immune microenvironment: mechanisms and therapeutic perspectives. MedComm Oncol. 2026;5:e70068. https:\/\/doi.org\/10.1002\/mog2.70068.","journal-title":"MedComm Oncol"},{"issue":"4","key":"3465_CR33","doi-asserted-by":"publisher","first-page":"188749","DOI":"10.1016\/j.bbcan.2022.188749","volume":"1877","author":"S Qin","year":"2022","unstructured":"Qin S, Li B, Ming H, Nice EC, Zou B, Huang C. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy. Biochim Biophys Acta Rev Cancer. 2022;1877(4):188749. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188749.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"3465_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, et al. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther. 2020;5(1):228. https:\/\/doi.org\/10.1038\/s41392-020-00313-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3465_CR35","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","volume":"10","author":"D Whitaker-Menezes","year":"2011","unstructured":"Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial lactate shuttle in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle. 2011;10(11):1772\u201383. https:\/\/doi.org\/10.4161\/cc.10.11.15659.","journal-title":"Cell Cycle"},{"issue":"12","key":"3465_CR36","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1172\/JCI36843","volume":"118","author":"P Sonveaux","year":"2008","unstructured":"Sonveaux P, V\u00e9gran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest. 2008;118(12):3930\u201342. https:\/\/doi.org\/10.1172\/JCI36843.","journal-title":"J Clin Invest"},{"issue":"3","key":"3465_CR37","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.gendis.2023.05.024","volume":"11","author":"Q Guo","year":"2024","unstructured":"Guo Q, Zhou Y, Xie T, Yuan Y, Li H, Shi W, et al. Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. Genes Dis. 2024;11(3):101043.","journal-title":"Genes Dis"},{"key":"3465_CR38","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.molmet.2024.102042","volume":"90","author":"WJ Smiles","year":"2024","unstructured":"Smiles WJ, Ovens AJ, Oakhill JS, Kofler B. The metabolic sensor AMPK: Twelve enzymes in one. Mol Metab. 2024;90:102042.","journal-title":"Mol Metab"},{"issue":"14","key":"3465_CR39","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.1074\/jbc.M113.545822","volume":"289","author":"S O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly S, Ciechomska M, Cant R, van Laar JM. Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem. 2014;289(14):9952\u201360.","journal-title":"J Biol Chem"},{"issue":"4","key":"3465_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.20517\/cdr.2022.20","volume":"5","author":"AR Safa","year":"2022","unstructured":"Safa AR. Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces. Cancer Drug Resist. 2022;5(4):850\u201372.","journal-title":"Cancer Drug Resist"},{"issue":"18","key":"3465_CR41","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1007\/s00018-015-1920-4","volume":"72","author":"H Qiu","year":"2015","unstructured":"Qiu H, Fang X, Luo Q, Ouyang G. Cancer stem cells: a potential target for cancer therapy. Cell Mol Life Sci. 2015;72(18):3411\u201324. https:\/\/doi.org\/10.1007\/s00018-015-1920-4.","journal-title":"Cell Mol Life Sci"},{"key":"3465_CR42","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3389\/fimmu.2020.01989","volume":"11","author":"J Cong","year":"2020","unstructured":"Cong J. Metabolism of Natural Killer Cells and Other Innate Lymphoid Cells. Front Immunol. 2020;11:1989.","journal-title":"Front Immunol"},{"issue":"1","key":"3465_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cpt.2022.09.001","volume":"1","author":"H Deng","year":"2023","unstructured":"Deng H, Chen Y, Li P, Hang Q, Zhang P, Jin Y, et al. PI3K\/AKT\/mTOR pathway, hypoxia, and glucose metabolism: Potential targets to overcome radioresistance in small cell lung cancer. Cancer Pathog Ther. 2023;1(1):56\u201366.","journal-title":"Cancer Pathog Ther"},{"issue":"1","key":"3465_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12943-025-02519-z","volume":"25","author":"S Zhang","year":"2026","unstructured":"Zhang S, Wang J, Xu Z, Cheng Z, Shao B, Yu J. Lactate: elucidating its indispensable role in human health. Mol Cancer. 2026;25(1):2.","journal-title":"Mol Cancer"},{"issue":"1","key":"3465_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol Rev. 2017;276(1):121\u201344.","journal-title":"Immunol Rev"},{"issue":"6","key":"3465_CR46","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.7150\/thno.105276","volume":"15","author":"H Wang","year":"2025","unstructured":"Wang H, Zhou F, Qin W, Yang Y, Li X, Liu R. Metabolic regulation of myeloid-derived suppressor cells in tumor immune microenvironment: targets and therapeutic strategies. Theranostics. 2025;15(6):2159\u201384.","journal-title":"Theranostics"},{"issue":"3","key":"3465_CR47","doi-asserted-by":"publisher","first-page":"151225","DOI":"10.1016\/j.ejcb.2022.151225","volume":"101","author":"J Di Gregorio","year":"2022","unstructured":"Di Gregorio J, Petricca S, Iorio R, Toniato E, Flati V. Mitochondrial and metabolic alterations in cancer cells. Eur J Cell Biol. 2022;101(3):151225.","journal-title":"Eur J Cell Biol"},{"key":"3465_CR48","doi-asserted-by":"publisher","first-page":"747863","DOI":"10.3389\/fcell.2021.747863","volume":"9","author":"J Li","year":"2021","unstructured":"Li J, Bolyard C, Xin G, Li Z. Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy. Front Cell Dev Biol. 2021;9:747863.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3465_CR49","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1172\/JCI79434","volume":"126","author":"AW Lund","year":"2016","unstructured":"Lund AW, Wagner M, Fankhauser M, Steinskog ES, Broggi MA, Spranger S, et al. Lymphatic vessels regulate immune microenvironments in human and murine melanoma. J Clin Invest. 2016;126(9):3389\u2013402. https:\/\/doi.org\/10.1172\/JCI79434.","journal-title":"J Clin Invest"},{"issue":"29","key":"3465_CR50","doi-asserted-by":"publisher","first-page":"45789","DOI":"10.18632\/oncotarget.9953","volume":"7","author":"ESS Steinskog","year":"2016","unstructured":"Steinskog ESS, Sagstad SJ, Wagner M, Karlsen TV, Yang N, Markhus CE, et al. Impaired lymphatic function accelerates cancer growth. Oncotarget. 2016;7(29):45789\u2013802. https:\/\/doi.org\/10.18632\/oncotarget.9953.","journal-title":"Oncotarget"},{"issue":"10","key":"3465_CR51","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.ajpath.2019.06.010","volume":"189","author":"M Wagner","year":"2019","unstructured":"Wagner M, Steinskog ES, Wiig H. Blockade of lymphangiogenesis shapes tumor-promoting adipose tissue inflammation. Am J Pathol. 2019;189(10):2102\u201314. https:\/\/doi.org\/10.1016\/j.ajpath.2019.06.010.","journal-title":"Am J Pathol"},{"issue":"10","key":"3465_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.trecan.2022.06.010","volume":"8","author":"M Wagner","year":"2022","unstructured":"Wagner M, Koyasu S. Cancer immunosurveillance by ILC2s. Trends Cancer. 2022;8(10):792\u20134. https:\/\/doi.org\/10.1016\/j.trecan.2022.06.010.","journal-title":"Trends Cancer"},{"issue":"8","key":"3465_CR53","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.celrep.2020.01.103","volume":"30","author":"M Wagner","year":"2020","unstructured":"Wagner M, Ealey KN, Tetsu H, Kiniwa T, Motomura Y, Moro K, et al. Tumor-derived lactic acid contributes to the paucity of intratumoral ILC2s. Cell Rep. 2020;30(8):2743\u2013e27575. https:\/\/doi.org\/10.1016\/j.celrep.2020.01.103.","journal-title":"Cell Rep"},{"issue":"8045","key":"3465_CR54","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-024-08194-2","volume":"637","author":"M Wagner","year":"2025","unstructured":"Wagner M, Nishikawa H, Koyasu S. Reinventing type 2 immunity in cancer. Nature. 2025;637(8045):296\u2013303. https:\/\/doi.org\/10.1038\/s41586-024-08194-2.","journal-title":"Nature"},{"key":"3465_CR55","doi-asserted-by":"publisher","first-page":"1735873","DOI":"10.3389\/fimmu.2025.1735873","volume":"16","author":"S Hu","year":"2025","unstructured":"Hu S, Heng H, Yang F, Wang M, Liu G, Xiang Y, et al. The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling. Front Immunol. 2025;16:1735873.","journal-title":"Front Immunol"},{"issue":"1","key":"3465_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","volume":"39","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res. 2020;39(1):112.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3465_CR57","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3465_CR58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-019-0963-9","volume":"18","author":"KM McAndrews","year":"2019","unstructured":"McAndrews KM, Kalluri R. Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer. 2019;18(1):52.","journal-title":"Mol Cancer"},{"issue":"6","key":"3465_CR59","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","volume":"25","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Oberstein PE, Thomas DH, Mirek ET, Palermo CF, Sastra SA, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014;25(6):735\u201347. https:\/\/doi.org\/10.1016\/j.ccr.2014.04.021.","journal-title":"Cancer Cell"},{"issue":"6","key":"3465_CR60","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334. https:\/\/doi.org\/10.1016\/j.ccr.2014.04.005.","journal-title":"Cancer Cell"},{"key":"3465_CR61","doi-asserted-by":"publisher","unstructured":"Shah S, D\u2019Souza GGM. Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis. Cells. 2025;14(10).:732. https:\/\/doi.org\/10.3390\/cells14100732","DOI":"10.3390\/cells14100732"},{"issue":"12","key":"3465_CR62","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1038\/s41401-022-01017-y","volume":"43","author":"LH Zhai","year":"2022","unstructured":"Zhai LH, Chen KF, Hao BB, Tan MJ. Proteomic characterization of post-translational modifications in drug discovery. Acta Pharmacol Sin. 2022;43(12):3112\u201329.","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"3465_CR63","first-page":"2377","volume":"19","author":"C Marbaniang","year":"2018","unstructured":"Marbaniang C, Kma L. Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells. Asian Pac J Cancer Prev. 2018;19(9):2377\u201390.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3465_CR64","first-page":"167","volume":"16","author":"E Elayeh","year":"2025","unstructured":"Elayeh E, Aleidi SM, Aboud O, Semreen MH, Bustanji YK, Dahabiyeh LA. Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC - Insights From Genomics, Proteomics, and Metabolomics. Lung Cancer (Auckl). 2025;16:167\u201398.","journal-title":"Lung Cancer (Auckl)"},{"key":"3465_CR65","doi-asserted-by":"publisher","first-page":"1055062","DOI":"10.3389\/fmed.2023.1055062","volume":"10","author":"P Gouel","year":"2023","unstructured":"Gouel P, Decazes P, Vera P, Gardin I, Thureau S, Bohn P. Advances in PET and MRI imaging of tumor hypoxia. Front Med (Lausanne). 2023;10:1055062.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"3465_CR66","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1158\/1078-0432.CCR-21-2972","volume":"28","author":"F Meric-Bernstam","year":"2022","unstructured":"Meric-Bernstam F, Tannir NM, Iliopoulos O, Lee RJ, Telli ML, Fan AC, et al. Telaglenastat plus cabozantinib or everolimus for advanced or metastatic renal cell carcinoma: an open-label phase I trial. Clin Cancer Res. 2022;28(8):1540\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2972.","journal-title":"Clin Cancer Res"},{"key":"3465_CR67","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1146\/annurev-pathmechdis-012418-012818","volume":"14","author":"S Ogino","year":"2019","unstructured":"Ogino S, Nowak JA, Hamada T, Milner DA Jr, Nishihara R. Insights into pathogenic interactions among environment, host, and tumor at the crossroads of molecular pathology and epidemiology. Annu Rev Pathol. 2019;14:83\u2013103. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-012418-012818.","journal-title":"Annu Rev Pathol"},{"key":"3465_CR68","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.lana.2025.101290","volume":"53","author":"S Ogino","year":"2025","unstructured":"Ogino S, Patel AV, Ugai S, Giannakis M, Ugai T. Unique role of the prospective cohort incident-tumor biobank method in etiological research. Lancet Reg Health Am. 2025;53:101290. https:\/\/doi.org\/10.1016\/j.lana.2025.101290.","journal-title":"Lancet Reg Health Am"},{"key":"3465_CR69","doi-asserted-by":"publisher","first-page":"128220","DOI":"10.1016\/j.envpol.2026.128220","volume":"400","author":"S Ugai","year":"2026","unstructured":"Ugai S, Mizuno H, Matsuda K, Kondo A, Zhong Y, Nakazawa N, et al. Cigarette smoking and long-term incidence of colorectal cancer subclassified by tumor-infiltrating myeloid cells: a prospective cohort study. Environ Pollut. 2026;400:128220. https:\/\/doi.org\/10.1016\/j.envpol.2026.128220.","journal-title":"Environ Pollut"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03465-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03465-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:01:57Z","timestamp":1792526517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03465-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03465-6","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have reported no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"335"}}